I. Butorin

Synthesis and biological evaluation of 6-nitro-1,2,4-triazoloazines containing polyphenol fragments possessing antioxidant and antiviral activity.

A. Slita, V. Zarubaev, V. Rusinov, 2020, Bioorganic & medicinal chemistry letters.

CK2 Inhibition and Antitumor Activity of 4,7-Dihydro-6-nitroazolo[1,5-a]pyrimidines

V. Rusinov, S. Kotovskaya, A. Spasov, 2022, Molecules.

Towards novel tacrine analogues: Pd(dppf)Cl2·CH2Cl2 catalyzed improved synthesis, in silico docking and hepatotoxicity studies

G. Zyryanov, S. Santra, O. Konovalova, 2022, RSC Advances.

Nitrothiadiazolo[3,2-a]pyrimidines as promising antiglycating agents.

R. Litvinov, V. Rusinov, P. Slepukhin, 2019, European journal of medicinal chemistry.

Azolo[5,1‐ c ][1,2,4]triazines and Azoloazapurines: Synthesis, Antimicrobial activity and in silico Studies

V. Rusinov, P. Slepukhin, N. Evstigneeva, 2022, ChemistrySelect.

Triazavirin—A Novel Effective Antiviral Drug

O. Chupakhin, V. Charushin, V. Rusinov, 2022, International journal of molecular sciences.

Indolyl-Derived 4H-Imidazoles: PASE Synthesis, Molecular Docking and In Vitro Cytotoxicity Assay

O. Chupakhin, V. Charushin, M. Varaksin, 2023, Processes.

Synthesis and cytotoxic activity of (2-arylquinazolin-4-yl)hydrazones of 2-hydroxybenzaldehydes

E. Nosova, S. Kotovskaya, I. Butorin, 2023, Chimica Techno Acta.